Ching C. Lau

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan et al. · Journal of Clinical Oncology · 2015 · 421 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma

Amar Gajjar, Roberto Hernán, Mehmet Koçak et al. · Journal of Clinical Oncology · 2004 · 281 citations · Full text

Medicine, Oncology, Pathology +17

Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection

Vidal Essebag, Atul Verma, Jeff S. Healey et al. · Journal of the American College of Cardiology · 2016 · 197 citations

Engineering, Infectious Diseases, Infection Prevention +6

Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study

E. Susan Amirian, Renke Zhou, Margaret Wrensch et al. · Cancer Epidemiology Biomarkers & Prevention · 2016 · 125 citations · Full text

Life Sciences, Immunology, Oncology +8

A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET

Murali Chintagumpala, Tim Hassall, Shawna L. Palmer et al. · Neuro-Oncology · 2008 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +17